Search

everythinglearnresearchcommunity

for

Search:↓

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

The PP2A-B55α protein is essential for brain and skin development in embryos.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Ritlecitinib is safe and may effectively treat alopecia areata.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

A patient developed a blister at the injection site after hepatitis C treatment.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

COVID-19 can harm male fertility by reducing sperm stem cells and damaging testicular function.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Diagnosing and managing Glucocorticoid Resistance Syndrome is complex due to genetic differences and varied symptoms.

A rare genetic disease causes rickets and often hair loss in young children, which can improve with specific treatments.

Two women with darker skin had both frontal hair thinning and skin discoloration.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Minoxidil helps hair regrowth in traction alopecia.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

This document studied minoxidil in healthy volunteers. Minoxidil is quickly absorbed and eliminated from the body.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.